COVID-19 Investigational Drugs and Supply Chain
After hearing about shortages of investigational drugs for COVID-19, I’ve pulled the relevant information to help drug manufacturers, suppliers, distributors, […]
General Biotechnology
Insights
244 Drug Patents With Claims Containing “consisting essentially of” may be Unenforceable
In a recent court ruling, the U.S. Court of Appeals for the Federal Circuit (CAFC) denied a petition to rehear arguments regarding the invalidity of patent claims containing the phrase…
The post 244 Drug Patents With Claims Containing “consisting essen…
244 Drug Patents With Claims Containing “consisting essentially of” may be Unenforceable Read Post »
Customer Success Stories, Insights
Customer Success: DrugPatentWatch for Your Library
One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation. They open with the statement that “The novelty, effectiveness and…
The post Customer Success: DrugPatentWatch for You…
Customer Success: DrugPatentWatch for Your Library Read Post »
Biotechnology in Countries Starting with “I” – Part 14: India
Earlier this month, I wrote here about the flowering of Israel’s innovative biotechnology sector over the past ten years following adoption of important
Biotechnology in Countries Starting with “I” – Part 14: India Read Post »
Biotechnology in Countries Starting with “I” – Part 13: Israel
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Biotechnology in Countries Starting with “I” – Part 13: Israel Read Post »
Update
Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities at the 13th Annual Pharma Resource Planning & Portfolio Management in Philadelphia, PA on February 6th, 2020. You can…
The post Upcoming Talk: Finding and Evaluating BioPharmace…
Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities Read Post »
Insights, Update
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey Fujimoto, Daniel M Tien, Sophie Snyder, Jeppe A Hertz, and…
The post The effect of patent expiration on sales of branded c…
Customer Success Stories, Insights, Tips, Tricks, and Case Studies
Customer Success: Will a generic version of a drug launch? And when?
DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation of which branded drugs will face generic competition, and when…
The post Customer Succe…
Customer Success: Will a generic version of a drug launch? And when? Read Post »
Customer Success Stories, Insights
Customer Success: API and CDMO Business Development
Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel…
The post Customer Success: API and CDMO Business Dev…
Customer Success: API and CDMO Business Development Read Post »
Customer Success Stories, Insights
Customer Success: API and CDMO Business Development
Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel…
The post Customer Success: API and CDMO Business Dev…
Customer Success: API and CDMO Business Development Read Post »
